Abstract
Ever-increasing demand for bone grafts necessitates the realization of clinical implementation of bone tissue engineered constructs. The predominant hurdle to implementation remains to be securing FDA approval, based on the lack of viable methods for the rigorous monitoring of said constructs. The study presented herein details a method for such monitoring based on the shifting metabolism of mesenchymal stem cells (MSCs) as they differentiate into osteoblasts. To that end, rat MSCs seeded on 85% porous spunbonded poly(L-lactic acid) scaffolds were cultured in flow perfusion bioreactors with baseline or osteoinductive media, and levels of key physio-metabolic markers (oxygen, glucose, osteoprotegerin, and osteocalcin) were monitored throughout culture. Comparison of these non-destructively obtained values and current standard destructive analyses demonstrated key trends useful for the concurrent real-time monitoring of construct cellularity and maturation. Principle among these is the elucidation of the ratio of the rates of oxygen uptake to glucose consumption as a powerful quality marker. This ratio, supported on a physiological basis, has been shown herein to be reliable in the determination of both construct maturation (defined as osteoblastic differentiation and accompanying mineralization) and construct cellularity. Supplementary monitoring of OPG and OCN are shown to provide further validation of such metrics.
Similar content being viewed by others
References
Alvarez-Barreto, J. F., S. M. Linehan, R. L. Shambaugh, and V. I. Sikavitsas. Flow perfusion improves seeding of tissue engineering scaffolds with different architectures. Ann. Biomed. Eng. 35:429–442, 2007.
Amini, A. R., C. T. Laurencin, and S. P. Nukavarapu. Bone tissue engineering: recent advances and challenges. Crit. Rev. Biomed. Eng. 40:363–408, 2012.
Bancroft, G. N., V. I. Sikavitsas, and A. G. Mikos. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng. 9:549–554, 2003.
Bone Graftat. http://www.healthline.com/health/bone-graft.
Chemistry, I. U. of P. and A. IUPAC Gold Book—Stern–Volmer kinetic relationshipsat. https://goldbook.iupac.org/html/S/S06004.html.
Chen, C.-T., Y.-R. V. Shih, T. K. Kuo, O. K. Lee, and Y.-H. Wei. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26:960–968, 2008.
dos Santos, F., P. Z. Andrade, J. S. Boura, M. M. Abecasis, C. L. da Silva, and J. M. S. Cabral. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol. 223:27–35, 2010.
Gómez-Barrena, E., P. Rosset, D. Lozano, J. Stanovici, C. Ermthaller, and F. Gerbhard. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone 70:93–101, 2015.
Guaccio, A., C. Borselli, O. Oliviero, and P. A. Netti. Oxygen consumption of chondrocytes in agarose and collagen gels: a comparative analysis. Biomaterials 29:1484–1493, 2008.
Komarova, S. V., F. I. Ataullakhanov, and R. K. Globus. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am. J. Physiol.-Cell Physiol. 279:C1220–C1229, 2000.
Krizan, S. J. The role of adhesion strength in human mesenchymal stem cell osteoblastic differentiation on biodegradable polymers., 2009.at https://deepblue.lib.umich.edu/bitstream/handle/2027.42/62260/skrizan_1.pdf;sequence=1.
Malda, J., T. B. F. Woodfield, F. van der Vloodt, F. K. Kooy, D. E. Martens, J. Tramper, C. A. van Blitterswijk, and J. Riesle. The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials 25:5773–5780, 2004.
Maniatopoulos, C., J. Sodek, and D. A. H. Melcher. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254:317–330, 1988.
Meuwly, F., F. Papp, P.-A. Ruffieux, A. R. Bernard, A. Kadouri, and U. von Stockar. Use of glucose consumption rate (GCR) as a tool to monitor and control animal cell production processes in packed-bed bioreactors. J. Biotechnol. 122:122–129, 2006.
Mikos, A. G., M. D. Lyman, L. E. Freed, and R. Langer. Wetting of poly(l-lactic acid) and poly(dl-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 15:55–58, 1994.
Nehring, D., P. Adamietz, N. M. Meenen, and R. Pörtner. Perfusion cultures and modelling of oxygen uptake with three-dimensional chondrocyte pellets. Biotechnol. Tech. 13:701–706, 1999.
Oryan, A., S. Alidadi, and A. Moshiri. Current concerns regarding healing of bone defects. Hard Tissue 2(2):1–12, 2013.
Oryan, A., S. Alidadi, A. Moshiri, and N. Maffulli. Bone regenerative medicine: classic options, novel strategies, and future directions. J. Orthop. Surg. 9:18, 2014.
Pattappa, G., H. K. Heywood, J. D. de Bruijn, and D. A. Lee. The metabolism of human mesenchymal stem cells during proliferation and differentiation. J. Cell. Physiol. 226:2562–2570, 2011.
Roberts, T. T., and A. J. Rosenbaum. Bone grafts, bone substitutes and orthobiologics. Organogenesis 8:114–124, 2012.
Santoro, R., C. Krause, I. Martin, and D. Wendt. On-line monitoring of oxygen as a non-destructive method to quantify cells in engineered 3D tissue constructs. J. Tissue Eng. Regen. Med. 6:696–701, 2012.
Sart, S., S. N. Agathos, and Y. Li. Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors. Biochem. Eng. J. 84:74–82, 2014.
Schop, D., F. W. Janssen, L. D. S. van Rijn, H. Fernandes, R. M. Bloem, J. D. de Bruijn, and R. van Dijkhuizen-Radersma. Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng. Part A 15:1877–1886, 2009.
Shyh-Chang, N., G. Q. Daley, and L. C. Cantley. Stem cell metabolism in tissue development and aging. Development 140:2535–2547, 2013.
Simmons, A. D., C. Williams III, A. Degoix, and V. I. Sikavitsas. Sensing metabolites for the monitoring of tissue engineered construct cellularity in perfusion bioreactors. Biosens: Bioelectron, 2017. doi:10.1016/j.bios.2016.09.094.
Tang, D., R. S. Tare, L.-Y. Yang, D. F. Williams, K.-L. Ou, and R. O. C. Oreffo. Biofabrication of bone tissue: approaches, challenges and translation for bone regeneration. Biomaterials 83:363–382, 2016.
Tissue Engineering. https://www.nibib.nih.gov/research-funding/tissue-engineering.
VanGordon, S. B., R. S. Voronov, T. B. Blue, R. L. Shambaugh, D. V. Papavassiliou, and V. I. Sikavitsas. Effects of scaffold architecture on preosteoblastic cultures under continuous fluid shear. Ind. Eng. Chem. Res. 50:620–629, 2011.
Funding
This work was financially supported by the Oklahoma Center for the Advancement of Science and Technology. (Grant # HR13-214).
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Jane Grande-Allen oversaw the review of this article.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Simmons, A.D., Sikavitsas, V.I. Monitoring Bone Tissue Engineered (BTE) Constructs Based on the Shifting Metabolism of Differentiating Stem Cells. Ann Biomed Eng 46, 37–47 (2018). https://doi.org/10.1007/s10439-017-1937-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-017-1937-y